It is not that cellule lung cancer treats the tactics that Chinese expert's clinical research changes later period

It is not that cellule lung cancer treats the tactics that Chinese expert's clinical research changes later period
Special triumphant a gleam of treatment Luo make EGFR it activates sudden change to be whether the intersection of cellule and patient have progress survive time lengthen nearly 3 times
A few days ago, the 35th European association of internal medicine - oncology (ESMO) Held in Milan of Italy. One of the academic activities of multi-disciplinary tumour cured before ESMO meeting is the whole world the most, attract include internal medicine - oncology, the intersection of tumour and dept. of radiology, the intersection of tumour and surgery, clinical former researcher and the intersection of relevant speciality and domain expert in all insiders inside.
With a previous and different one, at this conference, Vice President of the People's Hospital of Guangdong Province dragon's professor Wu, Tongji University the intersection of Shanghai and the intersection of lung and the intersection of department and the intersection of hospital and Zhou CaiCun Professor, head of the department of tumour, study and make conference's supreme specification theme speech on OPTIMAL. This result of study verifies, as to the epidermis growth factor receptor (EGFR) The person who didn't get cellule lung cancer of active sudden change, a gleam of uses the target to take the place of the Buddhist nun to the medicine strategic point Lip river, compared with a gleam of regular chemotherapy, the time of surviving of progress does not can improve about 3 times. Therapeutic tactics that will not be cellule lung cancer that this result of study will change later period. This is a Chinese expert's the first time to make conference's theme speech on the global top academic activity in the ambit of tumour, let the whole world listen to the sound of China, so, this result of study releases and treats the field to China and even international lung cancer but the speech has a milestone meaning.
Special triumphant a gleam of treatment Luo make EGFR it activates sudden change to be whether the intersection of cellule and patient have progress survive time lengthen nearly 3 times
According to the introduction of subject hospital tumour head of the department Professor Zhou CaiCun of lung of Shanghai of Tongji University, OPTIMAL result of study of this each reveals, a gleam of special Luo Kai? (strategic point Lip river takes the place of the Buddhist nun) Treatment unique the intersection of type and lung cancer patient have no time of surviving of progress ' Do not have progress life cycle - PFS) In over one year, lengthen nearly three times (location of China for 13.1 and 4.6 month more than patients who accept traditional chemotherapy, HR =0.16,plt; 0.0001).
One year later, pass special Luo Kai in all? Later period when EGFR treated activates sudden change exceeds half (56%) in the person who didn't get cellule lung cancer Patient disease by progress,but in accepting at chemotherapy the rate is 1.7% only. In addition, accept special Luo Kai? The proportion that tumour relieves takes place to the patient treating more than two times more than the patient who accept chemotherapy (83% and 36%; plt; 0.0001).

|